» Articles » PMID: 35959579

[Serum 25-hydroxyvitamin D Expression and Its Correlation in Patients with Vestibular Neuritis]

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

To investigate the expression level of serum 25-(OH) D and its correlation in patients with vestibular neuritis(VN). 30 acute VN patients and 50 age-and sex-matched healthy controls who attended the Otolaryngology, Head and Neck Surgery Department of the First Hospital of Shanxi Medical University from October 2020 to October 2021 were selected. The demographic and clinical data of all subjects were recorded, the levels of serum 25-(OH) D and inflammatory markers were measured and compared, and the changes of serum 25-(OH) D levels in convalescent patients with VN were followed up. The serum level of 25-(OH) D in the acute phase VN group was significantly lower than that in healthy controls[(10.14±2.92) ng/mL vs (20.61±4.70) ng/mL, <0.01], and the deficiency rate of 100.0%(30/30) was significantly higher than 54.0%(27/50). Moreover, the serum level of 25-(OH) D in the recovery period(3 months later) was significantly higher[(10.14±2.92) ng/mL vs (15.94±4.88) ng/mL, <0.01], and the deficiency rate was significantly decreased by 76.7%(23/30). However, the serum 25-(OH) D level was significantly lower in both the VN group than that in both the acute period and the recovery group, and the deficiency rate was significantly higher than that in the control group. Multivariate binary Logistic regression model analysis showed that low-level serum 25-(OH) D was associated with the onset of VN, with an OR value of 0.193(95%=0.043-0.861, =0.031). In addition, the results of this study showed that peripheral blood leukocyte(WBC) and neutrophil / lymphocyte ratio(NLR) levels in the acute VN group were significantly higher than in healthy controls[(7.65±3.02) ×10⁸/L vs (5.50±2.50) ×10⁸/L, <0.01; (2.46±2.95) ×100% vs(1.67±0.92) ×100%, <0.01 ], and there was no significant difference in Platelet / lymphocyte ratio(PLR) and and average platelet volume(MPV) levels in the two groups(>0.05). There were no significant differences in age distribution, sex ratio, body mass index, persistent health problems, or lifestyle groups(>0.05). This study is the first to detect serum 25-(OH) D level and inflammation index level, and dynamically assess the serum 25-(OH) D level in different stages, found that low serum 25-(OH) D is associated with the onset of VN, physiological concentration of serum 25-(OH) D is a protective factor of VN, vitamin D supplementation therapy may be a new target of VN treatment.

Citing Articles

Effects of vestibular rehabilitation training combined with anti-vertigo drugs on vertigo and balance function in patients with vestibular neuronitis: a systematic review and meta-analysis.

Chen J, Liu Z, Xie Y, Jin S Front Neurol. 2023; 14:1278307.

PMID: 38020604 PMC: 10666171. DOI: 10.3389/fneur.2023.1278307.

References
1.
Townsend K, Evans K, Campbell M, Colston K, Adams J, Hewison M . Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment. J Steroid Biochem Mol Biol. 2005; 97(1-2):103-9. DOI: 10.1016/j.jsbmb.2005.06.004. View

2.
Baecher-Allan C, Kaskow B, Weiner H . Multiple Sclerosis: Mechanisms and Immunotherapy. Neuron. 2018; 97(4):742-768. DOI: 10.1016/j.neuron.2018.01.021. View

3.
Himmelein S, Lindemann A, Sinicina I, Horn A, Brandt T, Strupp M . Differential Involvement during Latent Herpes Simplex Virus 1 Infection of the Superior and Inferior Divisions of the Vestibular Ganglia: Implications for Vestibular Neuritis. J Virol. 2017; 91(14). PMC: 5487553. DOI: 10.1128/JVI.00331-17. View

4.
Arbusow V, Derfuss T, Held K, Himmelein S, Strupp M, Gurkov R . Latency of herpes simplex virus type-1 in human geniculate and vestibular ganglia is associated with infiltration of CD8+ T cells. J Med Virol. 2010; 82(11):1917-20. DOI: 10.1002/jmv.21904. View

5.
Freedman J, Loscalzo J . Platelet-monocyte aggregates: bridging thrombosis and inflammation. Circulation. 2002; 105(18):2130-2. DOI: 10.1161/01.cir.0000017140.26466.f5. View